Literature DB >> 17484771

Differential regulation of lipopolysaccharide and Gram-positive bacteria induced cytokine and chemokine production in macrophages by Galpha(i) proteins.

Hongkuan Fan1, David L Williams, Basilia Zingarelli, Kevin F Breuel, Giuseppe Teti, George E Tempel, Karsten Spicher, Guylain Boulay, Lutz Birnbaumer, Perry V Halushka, James A Cook.   

Abstract

Heterotrimeric G(i) proteins play a role in signalling activated by lipopolysaccharide (LPS), Staphylococcus aureus (SA) and group B streptococci (GBS), leading to production of inflammatory mediators. We hypothesized that genetic deletion of G(i) proteins would alter cytokine and chemokine production induced by LPS, SA and GBS stimulation. LPS-induced, heat-killed SA-induced and heat-killed GBS-induced cytokine and chemokine production in peritoneal macrophages from wild-type (WT), Galpha(i2) (-/-) or Galpha(i1/3) (-/-) mice were investigated. LPS induced production of tumour necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), IL-10 and interferon-gamma-inducible protein-10 (IP-10); SA induced TNF-alpha, and IL-1beta production; and GBS induced TNF-alpha, IL-6, IL-1beta, macrophage inflammatory protein-1alpha (MIP-1alpha) and keratinocyte chemoattract (KC) production were all decreased (P < 0.05) in Galpha(i2) (-/-) or Galpha(i1/3) (-/-) mice compared with WT mice. In contrast to the role of G(i) proteins as a positive regulator of mediators, LPS-induced production of MIP-1alpha and granulocyte-macrophage colony-stimulating factor (GM-CSF) were increased in macrophages from Galpha(i1/3) (-/-) mice, and SA-induced MIP-1alpha production was increased in both groups of Galpha(i) protein-depleted mice. LPS-induced production of KC and IL-1beta, SA-induced production of GM-CSF, KC and IP-10, and GBS-induced production of IL-10, GM-CSF and IP-10 were unchanged in macrophages from Galpha(i2) (-/-) or Galpha(i1/3) (-/-) mice compared with WT mice. These data suggest that G(i2) and G(i1/3) proteins are both involved and differentially regulate murine inflammatory cytokine and chemokine production in response to both LPS and Gram-positive microbial stimuli.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484771      PMCID: PMC2265979          DOI: 10.1111/j.1365-2567.2007.02619.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  A CD14-independent LPS receptor cluster.

Authors:  K Triantafilou; M Triantafilou; R L Dedrick
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  Molecular characterization of a human scavenger receptor, human MARCO.

Authors:  N A Elshourbagy; X Li; J Terrett; S Vanhorn; M S Gross; J E Adamou; K M Anderson; C L Webb; P G Lysko
Journal:  Eur J Biochem       Date:  2000-02

3.  Mastoparan, a G protein agonist peptide, differentially modulates TLR4- and TLR2-mediated signaling in human endothelial cells and murine macrophages.

Authors:  Arnd Lentschat; Hisae Karahashi; Kathrin S Michelsen; Lisa S Thomas; Wenxuan Zhang; Stefanie N Vogel; Moshe Arditi
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

4.  Signal transduction events in Chinese hamster ovary cells expressing human CD14; effect of endotoxin desensitization.

Authors:  M Ferlito; F Squadrito; P V Halushka; J A Cook
Journal:  Shock       Date:  2001-04       Impact factor: 3.454

5.  Lipopolysaccharide- and gram-positive bacteria-induced cellular inflammatory responses: role of heterotrimeric Galpha(i) proteins.

Authors:  Hongkuan Fan; Basilia Zingarelli; Octavia M Peck; Giuseppe Teti; George E Tempel; Perry V Halushka; Karsten Spicher; Guylain Boulay; Lutz Birnbaumer; James A Cook
Journal:  Am J Physiol Cell Physiol       Date:  2005-03-23       Impact factor: 4.249

6.  Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection.

Authors:  O Takeuchi; K Hoshino; S Akira
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

7.  Chemokines are the main proinflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin.

Authors:  Z M Wang; C Liu; R Dziarski
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

Review 8.  Increasing threat of Gram-positive bacterial infections in the intensive care unit setting.

Authors:  J E McGowan
Journal:  Crit Care Med       Date:  2001-04       Impact factor: 7.598

9.  Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages.

Authors:  M Hirschfeld; J J Weis; V Toshchakov; C A Salkowski; M J Cody; D C Ward; N Qureshi; S M Michalek; S N Vogel
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

10.  Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain.

Authors:  Lynda M Stuart; Jiusheng Deng; Jessica M Silver; Kazue Takahashi; Anita A Tseng; Elizabeth J Hennessy; R Alan B Ezekowitz; Kathryn J Moore
Journal:  J Cell Biol       Date:  2005-08-01       Impact factor: 10.539

View more
  14 in total

1.  Gαi1 and Gαi3 regulate macrophage polarization by forming a complex containing CD14 and Gab1.

Authors:  Xianjing Li; Duowei Wang; Zhen Chen; Ermei Lu; Zhuo Wang; Jingjing Duan; Wei Tian; Yun Wang; Linjun You; Yulian Zou; Yan Cheng; Qingyi Zhu; Xiaojian Wan; Tao Xi; Meisheng Jiang; Yuyuan Han; Cong Cao; Lutz Birnbaumer; Wen-Ming Chu; Yong Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

2.  Two novel functions of hyaluronidase from Streptococcus agalactiae are enhanced intracellular survival and inhibition of proinflammatory cytokine expression.

Authors:  Zhaofei Wang; Changming Guo; Yannan Xu; Guangjin Liu; Chengping Lu; Yongjie Liu
Journal:  Infect Immun       Date:  2014-04-07       Impact factor: 3.441

3.  Beta-arrestin 2 negatively regulates sepsis-induced inflammation.

Authors:  Hongkuan Fan; Alessandra Bitto; Basilia Zingarelli; Louis M Luttrell; Keith Borg; Perry V Halushka; James A Cook
Journal:  Immunology       Date:  2010-05-04       Impact factor: 7.397

4.  CCR8 signaling influences Toll-like receptor 4 responses in human macrophages in inflammatory diseases.

Authors:  Martina Kvist Reimer; Charlotte Brange; Alexander Rosendahl
Journal:  Clin Vaccine Immunol       Date:  2011-10-05

Review 5.  Implications of non-canonical G-protein signaling for the immune system.

Authors:  Cédric Boularan; John H Kehrl
Journal:  Cell Signal       Date:  2014-02-28       Impact factor: 4.315

6.  Protective effects of N-acetylcysteine in isoproterenol-induced myocardium injury in rats.

Authors:  Bin Liu; Weimin Li; Yue Li; Zhonghua Wang; Hongli Li; Ping Liu; Jun Fu
Journal:  Mol Biol Rep       Date:  2008-04-04       Impact factor: 2.316

7.  Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity.

Authors:  Elena Gabrielli; Eva Pericolini; Elio Cenci; Federica Ortelli; Walter Magliani; Tecla Ciociola; Francesco Bistoni; Stefania Conti; Anna Vecchiarelli; Luciano Polonelli
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

8.  Local and systemic chemokine patterns in a human musculoskeletal trauma model.

Authors:  Daniel Bastian; Margareth Vislie Tamburstuen; Ståle Petter Lyngstadaas; Olav Reikerås
Journal:  Inflamm Res       Date:  2009-03-10       Impact factor: 4.575

9.  Group B Streptococcus and Streptococcus suis capsular polysaccharides induce chemokine production by dendritic cells via Toll-like receptor 2- and MyD88-dependent and -independent pathways.

Authors:  Cynthia Calzas; Guillaume Goyette-Desjardins; Paul Lemire; Fleur Gagnon; Claude Lachance; Marie-Rose Van Calsteren; Mariela Segura
Journal:  Infect Immun       Date:  2013-06-17       Impact factor: 3.441

10.  Gαi2 Signaling Regulates Inflammasome Priming and Cytokine Production by Biasing Macrophage Phenotype Determination.

Authors:  Ali Vural; Neel R Nabar; Il-Young Hwang; Silke Sohn; Chung Park; Mikael C I Karlsson; Joe B Blumer; John H Kehrl
Journal:  J Immunol       Date:  2019-01-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.